News
The artificial intelligence-based assay relies on images from an H&E stained biopsy slide and a machine learning model to determine risk of metastasis.
Patients with migraine with aura show reduced migraine symptoms, less rescue medication use, and more sustained pain relief with eTNS.
Phase 3 Top Line Results Expected Q2 2026 SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its ...
MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA® ...
1h
AllAfrica on MSNUgandan Made Diabetes, Malaria Drugs in Final Stages, Says Minister MuseneroThe Minister for Science, Technology and Innovation, Dr. Monica Musenero said Ugandan made Diabetes and Malaria drugs are in the final stages of being rolled out.Addressing journalists following the ...
2h
ScienceAlert on MSNPromising New Drug For Weight Loss Works With Just One Monthly DoseDrugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...
Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...
ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...
The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe ...
Testosterone therapy did not improve walking distance in older women recovering from hip fracture compared to exercise alone, ...
Hibiscus, ginger, garlic, cinnamon, and other herbs may help lower blood pressure naturally. Practical tips can help you add ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results